Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6
- 31 December 1993
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (11), 1584-1589
- https://doi.org/10.1016/0959-8049(93)90299-u
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's diseaseThe Lancet, 1991
- The Role of Methylation in the Phenotype-dependent Modulation of Epstein-Barr Nuclear Antigen 2 and Latent Membrane Protein Genes in Cells Latently Infected with Epstein-Barr VirusJournal of General Virology, 1989
- DETECTION OF A SECOND WIDESPREAD STRAIN OF EPSTEIN-BARR VIRUSThe Lancet, 1989
- Viral latency and transformation: The strategy of Epstein-Barr virusCell, 1989
- Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinomaInternational Journal of Cancer, 1988
- Prevalence of Antibodies to Epstein-Barr Virus Nuclear Antigen 2B in Persons Infected with the Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1988
- Epstein--Barr Virus Gene Expression in Nasopharyngeal CarcinomaJournal of General Virology, 1988
- Stable transfection of a human lymphoma line by sub‐genomic fragments of Epstein‐Barr virus DNA to measure humoral and cellular immunity to the corresponding proteinsInternational Journal of Cancer, 1987
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985
- Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell linesInternational Journal of Cancer, 1973